Combined G-CSF and Plerixafor enhance hematopoietic recovery of CD34+ cells from poor mobilizer patients in NSG mice-Reference-Cited by-同舟云学术

Combined G-CSF and Plerixafor enhance hematopoietic recovery of CD34+ cells from poor mobilizer patients in NSG mice

Published:2020-06 Issue: Volume:86 Page:15-20.e2
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Arcangeli Marie-Laure^ORCID,Brault Philippe,Bourhis Jean-Henri,Kuhnowskie Frédérique,Henry Elia,Barroca Vilma,Koscielny Serge,Pflumio Françoise,Amsellem Sophie

Funder

Institut National de la Santé et de la Recherche Médicale

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference27 articles.

1. How I treat patients who mobilize hematopoietic stem cells poorly;To;Blood,2011

2. Stem cells: units of development, units of regeneration, and units in evolution;Weissman;Cell,2000

3. The biology and clinical uses of blood stem cells;To;Blood,1997

4. Current status of stem cell mobilization;Gertz;Br J Haematol,2010

5. In and out of the niche: perspectives in mobilization of hematopoietic stem cells;Mohty;Exp Hematol,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of CD34+ Cell Count at Different Time Points Following Plerixafor Administration in Autologous Hematopoietic Stem Cell Transplantation;International Journal of Cancer Management;2022-08-20

2. Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan;eJHaem;2022-07-21

3. Acute and endothelial-specific Robo4 deletion affect hematopoietic stem cell trafficking independent of VCAM1;PLOS ONE;2021-08-13